In relation to primary melanoma, NRAS mutations have been associated with thicker lesions, higher mitotic rates, nodular primary subtype, and nodal relapse compared to BRAF-mutated and wild-type melanoma [5,15]. The gene discussed is NRAS; the disease is melanoma.